Group 1: New Stock Offerings - Jichuan Pharmaceutical (600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - *ST Yazhen (603389) has a tender offer period from June 10, 2025, to July 9, 2025[1] Group 2: Delisting Information - *ST Gongzhi (000584) will enter the delisting arrangement period starting June 20, 2025[1] - Delisting Haiyue (600387) has 14 trading days remaining until the last trading day[1] - Renle Tui (002336) has 13 trading days remaining until the last trading day[1] - Delisting Longyu (603003) has 10 trading days remaining until the last trading day[1] - Delisting Pengbo (600804) has 10 trading days remaining until the last trading day[1] - Longjin Tui (002750) has 8 trading days remaining until the last trading day[1] Group 3: Abnormal Fluctuations - Lianhua Technology (002250) reported severe abnormal fluctuations[1] - ST Kailin (002425) reported abnormal fluctuations[1] - ST Xianfeng (002141) reported abnormal fluctuations[1] - ST Shihuan (000518) reported abnormal fluctuations[1]

Core Viewpoint - Two A-share listed companies, *ST Pengbo and *ST Longyu, have received decisions for stock delisting, entering the delisting preparation period on June 10, 2025 [1][5]. Group 1: *ST Pengbo - *ST Pengbo announced the termination of its stock listing due to an audit report for the 2023 fiscal year that could not express an opinion, leading to a delisting risk warning from May 6, 2024 [3]. - The company reported a revenue of 1.877 billion yuan for 2024, a decrease of 27.99% year-on-year, and a net loss attributable to shareholders of 885 million yuan [4]. - The stock will enter a delisting preparation period starting June 10, 2025, with an expected last trading day on June 30, 2025, and will continue trading on the risk warning board during this period [3][4]. Group 2: *ST Longyu - *ST Longyu also received a decision for stock termination, with the same delisting preparation period starting on June 10, 2025, and an expected last trading day on June 30, 2025 [5]. - The company reported a revenue of 1.405 billion yuan for 2024, a significant decrease of 55.02% year-on-year, and a net loss attributable to shareholders of 332 million yuan [6]. - The chairman of *ST Longyu, Xu Zengzeng, recently resigned due to personal and health reasons, but the company's control has not changed [5][6].